The Togolese Medicinal Recipe, Diabeto-Dolvo® Exerted Antidiabetic Effects in Wistar Rats

H. E. Gbekley, K. Idoh, Nassifatou Titikpina, Kodjovi Agbodeka, K. Anani, G. Katawa, B. Djeri, T. Tchacondo, S. Karou, Y. Ameyapoh, S. Jacques
{"title":"The Togolese Medicinal Recipe, Diabeto-Dolvo® Exerted Antidiabetic Effects in Wistar Rats","authors":"H. E. Gbekley, K. Idoh, Nassifatou Titikpina, Kodjovi Agbodeka, K. Anani, G. Katawa, B. Djeri, T. Tchacondo, S. Karou, Y. Ameyapoh, S. Jacques","doi":"10.35759/JABS.157.8","DOIUrl":null,"url":null,"abstract":"Objective: this study was to evaluate the toxicity of a herbal recipe Diabeto-Dolvo® (DD) and its efficacy in streptozotocin-induced diabetic Wistar rats. Methodology and results: The toxicity test was performed by oral administration of the extract to rats while diabetes was induced with streptozotocin, the 250, and 500 mg / kg body weight. The results of the toxicity tests revealed no evidence of mortality or morbidity suggesting an LD50 greater than 5000 mg / kg. Similarly, the biochemical and haematological parameters remained unchanged. In antidiabetic tests, there was a progressive decrease followed by a normalization of the glucose level of the treated rats. Overall, the extract at 250 and 500 mg / kg body weight resulted in a significant reduction in glycated haemoglobin, amylase, lipase, G6PD and serum lipids. Conclusion and application of results: This study revealed that, the treatment with the recipe might repair oxidative damages, hyperglycaemia and hyperlipidaemia in diabetic rats in the same way as the treatment with glibenclamide. This study is a contribution to the experimental validation of the DD recipe. In research and development application, the DD recipe will be used in the treatment of cases of diabetes mellitus. A natural product, it will support the multiple treatments of so-called conventional medicine, relatively expensive for the population.","PeriodicalId":14998,"journal":{"name":"Journal of Applied Biosciences","volume":"1 1","pages":"16223-16236"},"PeriodicalIF":0.0000,"publicationDate":"2021-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Applied Biosciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35759/JABS.157.8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Objective: this study was to evaluate the toxicity of a herbal recipe Diabeto-Dolvo® (DD) and its efficacy in streptozotocin-induced diabetic Wistar rats. Methodology and results: The toxicity test was performed by oral administration of the extract to rats while diabetes was induced with streptozotocin, the 250, and 500 mg / kg body weight. The results of the toxicity tests revealed no evidence of mortality or morbidity suggesting an LD50 greater than 5000 mg / kg. Similarly, the biochemical and haematological parameters remained unchanged. In antidiabetic tests, there was a progressive decrease followed by a normalization of the glucose level of the treated rats. Overall, the extract at 250 and 500 mg / kg body weight resulted in a significant reduction in glycated haemoglobin, amylase, lipase, G6PD and serum lipids. Conclusion and application of results: This study revealed that, the treatment with the recipe might repair oxidative damages, hyperglycaemia and hyperlipidaemia in diabetic rats in the same way as the treatment with glibenclamide. This study is a contribution to the experimental validation of the DD recipe. In research and development application, the DD recipe will be used in the treatment of cases of diabetes mellitus. A natural product, it will support the multiple treatments of so-called conventional medicine, relatively expensive for the population.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多哥药方diabtodolvo®对Wistar大鼠的降糖作用
目的:研究中药方Diabeto-Dolvo®(DD)对链脲佐菌素(streptozotocin)诱导的糖尿病大鼠的毒性及疗效。方法与结果:采用链脲佐菌素、250 mg / kg、500 mg / kg诱导大鼠患糖尿病的方法进行毒性试验。毒性试验结果显示,没有证据表明LD50大于5000 mg / kg会导致死亡或发病。同样,生化和血液学参数保持不变。在抗糖尿病试验中,治疗大鼠的血糖水平逐渐下降,随后恢复正常。总的来说,250和500 mg / kg体重的提取物显著降低了糖化血红蛋白、淀粉酶、脂肪酶、G6PD和血脂。结论及结果应用:本研究表明,该方对糖尿病大鼠氧化损伤、高血糖、高脂血症的修复作用与格列苯脲治疗作用相同。本研究对DD方剂的实验验证有一定的贡献。在研发应用方面,DD方剂将用于治疗糖尿病病例。作为一种天然产品,它将支持所谓的传统医学的多种治疗方法,对人们来说相对昂贵。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The Chaperone Hsp90, a Key Player in Salivary Gland Tumorigenesis Determination of Target Crop Loads for Maximising Fruit Quality and Return Bloom in Several Apple Cultivars Agrigenomic Diversity Unleashed: Current Single Nucleotide Polymorphism Genotyping Methods for the Agricultural Sciences The Food-Crushing Reflex and Its Inhibition Effects of Patterned Electromagnetic Fields and Light-Emitting Diodes on Cancer Cells: Impact on Cell Density and Biophoton Emission When Applied Individually vs. Simultaneously
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1